Kevin C. Gorman
Overview
Kevin C. Gorman received an average of $9M in total compensation, including $671K in salary, at Neurocrine Biosciences from 2014 to 2021.
2021Neurocrine BiosciencesChief Executive Officer
2020Neurocrine BiosciencesChief Executive Officer
2019Neurocrine BiosciencesChief Executive Officer
2018Neurocrine BiosciencesChief Executive Officer
2017Neurocrine BiosciencesChief Executive Officer
2016Neurocrine BiosciencesPresident and Chief Executive Officer
2015Neurocrine BiosciencesPresident and Chief Executive Officer
2014Neurocrine BiosciencesPresident and Chief Executive Officer
Source: SEC filings on April 7, 2022, April 9, 2021, April 9, 2020, April 17, 2019, and April 20, 2017.
Related executives
We found eight more executives who work or worked at Neurocrine Biosciences.
Jude Onyia
Neurocrine Biosciences
Chief Scientific Officer
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
Christopher O'Brien
Neurocrine Biosciences
Chief Medical Officer
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019